BioCentury
ARTICLE | Clinical News

Crolibulin: Phase I/II started

January 3, 2011 8:00 AM UTC

The National Cancer Institute began an open-label, U.S. Phase I/II trial in up to 70 patients. The dose-escalation Phase I portion of the trial will evaluate crolibulin plus cisplatin given in 21-day...